I Watched Star Trek: Generations For The 30th Anniversary, And There's One Thing It Does Better Than Any Other Movie In The Franchise
TOMS RIVER, N.J. — A U.S. senator has called for mysterious drones spotted flying at night over sensitive areas in New Jersey and other parts of the Mid-Atlantic region to be “shot down, if necessary,” even as it remains unclear who owns the unmanned aircraft. “We should be doing some very urgent intelligence analysis and take them out of the skies, especially if they’re flying over airports or military bases,” Sen. Richard Blumenthal of Connecticut said Thursday, as concerns about the drones spread across Capitol Hill. People in the New York region are also concerned that the drones may be sharing airspace with commercial airlines, he said, demanding more transparency from the Biden administration. The White House said Thursday that a review of the reported sightings shows that many of them are actually manned aircraft being flown lawfully. White House National Security spokesman John Kirby said there were no reported sightings in any restricted airspace. He said the U.S. Coast Guard has not uncovered any foreign involvement from coastal vessels. “We have no evidence at this time that the reported drone sightings pose a national security or a public safety threat, or have a foreign nexus,” Kirby said, echoing statements from the Pentagon and New Jersey Gov. Phil Murphy. Pentagon spokesperson Sabrina Singh has said they are not U.S. military drones. In a joint statement issued Thursday afternoon, the FBI and the Department of Homeland Security said they and their federal partners, in close coordination with the New Jersey State Police, “continue to deploy personnel and technology to investigate this situation and confirm whether the reported drone flights are actually drones or are instead manned aircraft or otherwise inaccurate sightings.” The agencies said they have not corroborated any of the reported sightings with electronic detection, and that reviews of available images appear to show many of the reported drones are actually manned aircraft. “There are no reported or confirmed drone sightings in any restricted air space,” according to the statement. The drones appear to avoid detection by traditional methods such as helicopter and radio, according to a state lawmaker briefed Wednesday by the Department of Homeland Security. The number of sightings has increased in recent days, though officials say many of the objects seen may have been planes rather than drones. It’s also possible that a single drone has been reported more than once. The worry stems partly from the flying objects initially being spotted near the Picatinny Arsenal, a U.S. military research and manufacturing facility, and over President-elect Donald Trump’s golf course in Bedminster. In a post on the social media platform X, Assemblywoman Dawn Fantasia described the drones as up to 6 feet (1.8 meters) in diameter and sometimes traveling with their lights switched off. Drones are legal in New Jersey for recreational and commercial use but are subject to local and Federal Aviation Administration regulations and flight restrictions. Operators must be FAA certified. Most, but not all, of the drones spotted in New Jersey appeared to be larger than those typically used by hobbyists. Sen. Cory Booker of New Jersey said he was frustrated by the lack of transparency, saying it could help spread fear and misinformation. “We should know what’s going on over our skies,” he said Thursday. John Duesler, president of the Pennsylvania Drone Association, said witnesses may be confused about what they are seeing, especially in the dark, and noted it’s hard to know the size of the drones or how close they might be. “There are certainly big drones, such as agricultural drones, but typically they are not the type you see flying around in urban or suburban spaces,” Duesler said Thursday. Duesler said the drones — and those flying them — likely cannot evade detection. “They will leave a radio frequency footprint, they all leave a signature,” he said. “We will find out what kind of drones they were, who was flying them and where they were flying them.” Fantasia, a Morris County Republican, was among several lawmakers who met with state police and Homeland Security officials to discuss the sightings from the New York City area across New Jersey and westward into parts of Pennsylvania, including over Philadelphia. It is unknown at this time whether the sightings are related. Duesler said the public wants to know what’s going on. “I hope (the government agencies) will come out with more information about this to ease our fears. But this could just be the acts of rogue drone operators, it’s not an ‘invasion’ as some reports have called it,” Duesler said. “I am concerned about this it but not alarmed by it.”
Mawson Infrastructure Group Inc. ( OTCMKTS:WIZP – Get Free Report )’s stock price traded down 4.8% on Friday . The stock traded as low as $0.92 and last traded at $0.95. 388,687 shares were traded during trading, an increase of 175% from the average session volume of 141,517 shares. The stock had previously closed at $1.00. Mawson Infrastructure Group Trading Down 3.2 % The company has a market cap of $447.61 million, a price-to-earnings ratio of -2.05 and a beta of 1.77. The business has a fifty day moving average price of $1.56 and a two-hundred day moving average price of $1.44. About Mawson Infrastructure Group ( Get Free Report ) Mawson Infrastructure Group, Inc engages in the provision of digital asset infrastructure services. The company is headquartered in North Sydney, Australia. Featured Articles Receive News & Ratings for Mawson Infrastructure Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mawson Infrastructure Group and related companies with MarketBeat.com's FREE daily email newsletter .Entrada Therapeutics president sells $320,619 in stock
Independent engineer says he gave Prasa opportunity to comment on Siyangena valuationTUCSON, Ariz. (KGUN) — El Tour de Tucson is an iconic event, showcasing a Southern Arizona landscape that is perfect for cyclists. Over the past few years, more and more adaptive cyclists have taken part in El Tour. KGUN 9's Ryan Fish will be LIVE in this evening's newscasts alongside Pat Parris and our full Midtown/Downtown reporting team, bringing you more stories from El Tour and Downtown Tucson. Watch here at 5 & 6pm. Nonprofit Southern Arizona Adaptive Sports —along with its sponsor, for-profit business Omeo America —has its own team dedicated to the cause: Team Access. Adam Finney has been riding hand cycles for nearly two decades. “Cycling really was important to me when I got injured almost 20 years ago,” he told KGUN. “And so I just believe getting people outside, having a sense of freedom, is really important.” After a couple of 100-mile El Tour rides, this year he’s dialing it back to the 32-miler. “Just to be around more of the team and just enjoy the community, the cycling community more,” he explained. That community rides together on Team Access. This year is its biggest yet. “We have a few riders this year that first time on bikes in almost 25 years,” Finney pointed out. This year, 136 riders are on the team, made up of adaptive cyclists, and family and friends like Jon Bialis. “My son was a wheelchair user a few years back and we borrowed a hand cycle,” he recalled. “[Cycling] provides tremendous mental and physical benefit... [Adaptive equipment] just allows them to participate at the same level as everyone else.” RELATED | El Tour For All: Transfer boards make rides easier for adaptive athletes The equipment catered to adaptive athletes—a combination of recumbent bikes, trikes, hand cycles, and tandems—can each cost thousands of dollars. That’s why the Eduardo Aguirre Adaptive Cycling Center at Kino Sports Complex is open year-round, giving adaptive riders a chance to try out these bikes before buying them. “We’re also here not just to ride but if people need to get out and just have a community, that’s a big part of this cycling center as well,” said Finney. On Saturday, they will be riding and raising money during El Tour, hoping next year even more people will be along for the ride. CLICK HERE TO SUPPORT SOUTHERN ARIZONA ADAPTIVE SPORTS There are many adaptive athletes riding in El Tour this year aside from those on Team Access. Their experience has been getting smoother the past few years: El Tour has added ADA accessible bathrooms, a sign language interpreter at the start line, unique start lines and accessible parking, through the help of Omeo. ——- Ryan Fish is an anchor and reporter for KGUN 9 and comes to the Sonoran Desert from California’s Central Coast after working as a reporter, sports anchor and weather forecaster in Santa Barbara. Ryan grew up in the Chicago suburbs, frequently visiting family in Tucson. Share your story ideas and important issues with Ryan by emailing ryan.fish@kgun9.com or by connecting on Facebook and Twitter .
Hampton will require owners of vacant buildings to register them
Significant milestones in life and career of Jimmy Carter
Social media is expected to further influence customer service and retail spaces during 2025. New survey insights (2,000 U.S. and U.K. consumers) reveal how users expect to engage with social media in 2025 . Across all users, approximately even amounts (29-34 percent) plan to use Facebook, YouTube, Instagram and TikTok more in 2025, while 24 percent of respondents do not plan to use any social networks more in 2025. When it comes to trust in social media, 63 percent of users somewhat trust social media networks to protect their personal data. Only 22 percent completely trust social media networks, and 16 percent do not trust them at all. Complete trust is higher among Gen Z and Millennials (28 percent and 29 percent) than among Gen X and Baby Boomers (19 percent and 10 percent). Specific to what brands should prioritize on social media in 2025, most respondents say personalized customer service (40 percent) or selling products directly through social platforms (29 percent) are important to them. Sprout Social’s CMO, Scott Morris has shared insights with Digital Journal what to expect and how marketing leaders can stay ahead. Prediction #1: Dominance In 2025, social media will dominate the customer service game. Everyone, especially younger generations, is turning to platforms like Facebook and Instagram first to get their customer service questions answered quickly. And the expectation for speed and personalization has never been higher. In fact, Sprout Social’s most recent Index report shows that 69 percent of people expect a response within 24 hours of reaching out on social media, and 70 percent expect those responses to be personalized. To meet these rising expectations, brands will have to learn to strike a balance between automation and human touch, dispersing AI to handle routine inquiries while leaving customer care teams to focus on complex issues. Prediction #2: Platforms remaining on top Social platforms like Facebook, Instagram, and TikTok will be the top shopping destinations for consumers in 2025. People’s plans for the holiday shopping season are evidence of that. Sprout Social’s Q4 2024 Pulse Survey found that 42 percent of shoppers plan to use social media more to find gifts, with social influencer recommendations being the #1 source of gift inspiration across all respondents, up from the fifth source one year ago. That same survey found that 32 percent of consumers plan to make more purchases directly through social channels in 2025, giving brands the opportunity to use social media to facilitate a complete customer journey, from discovery to post-purchase. With this influx of buyers, AI-driven customer care will play a critical role, offering real-time responses and tailored product recommendations to enhance customer experience. Dr. Tim Sandle is Digital Journal's Editor-at-Large for science news.Tim specializes in science, technology, environmental, business, and health journalism. He is additionally a practising microbiologist; and an author. He is also interested in history, politics and current affairs.Lil Wayne, GloRilla, Camila Cabello to perform at College Football National Championship
Clayton scores 34 as Ohio knocks off Portland 85-73The year in review: Influential people who died in 2024
ASP Isotopes Inc. Responds to Short Seller ReportUS Senate chaplain Barry Black hospitalized after brain bleedSergel is heading towards generating Tk 1,000 crore in annual sales as over Tk 900 crore worth of the gastrological medicine was sold in the first nine months of this year, according to information technology company IMS Health. This is one of the largest selling products in the country. Md Halimuzzaman, CEO of Healthcare Pharmaceuticals Ltd, said he was proud of this single brand of the company reaching such high sales, although it had not reached Tk 1,000 crore yet. Since the customer base is high, the sales growth now appears low compared to previous years but there is potential for further growth, he said. The second and third-highest selling medicine brands are also from the same gastrological generic. Sales of Maxpro and Pantonix have reached Tk 486 crore and Tk 376 crore respectively. In the pharmaceuticals market, the market share of gastrologic products is the highest and Sergel has earned the highest market share over the years for its acceptance among doctors and patients, said Halimuzzaman. Among the 10 top-selling drug brands, five are gastrological medicines. Sergel holds a 2.67 percent market share, with sales worth Tk 918 crore in the nine-month period. Maxpro holds a 1.41 percent market share and the market share of Pantonix is 1.10 percent, the data showed. Apart from Sergel, some other brands have become popular over the years, said Halimuzzaman. The fourth-highest selling drug in the nine months period was Napa, with sales reaching Tk 338 crore. Sales of Cef-3, Monas, Exium, Seclo and Bizoran are also above Tk 200 crore. Almost all the drug companies have their own brands of these drugs, which bear the same molecular formula, but some gained popularity on gaining people's confidence. And this confidence passes from person to person, he said. There are 31 generic drugs that sell for over Tk 100 crore. The data showed that sales of 79 generic medicine were above Tk 50 crore. The data indicates that although the sales of individual brands of products of some companies may not be high, but the brand value of the companies themselves ensures high sales of all their medicines. Jubayer Alam, company secretary of Renata PLC, said most people over 18 years of age take gastrological medicine as there is no discipline when it comes to food intake and habits. Due to this, many people suffer from ailments affecting the digestive system, he said. Demand is growing for rosuvastatin drugs, which lowers cholesterol, as many people are dying of heart attacks, he added. Even in developed countries, demand for such medicine is growing, so it also may see a good growth in the country, he added. "We are really happy that we can serve a huge number of patients to overcome ulcer, gastroesophageal reflux disease and hyperacidity related problems with Maxpro," Alam said. "All Maxpro formulations are manufactured in USFDA, UKMHRA and Anvisa approved facilities so that patients get the best esomeprazole of the country," he added. Sergel is heading towards generating Tk 1,000 crore in annual sales as over Tk 900 crore worth of the gastrological medicine was sold in the first nine months of this year, according to information technology company IMS Health. This is one of the largest selling products in the country. Md Halimuzzaman, CEO of Healthcare Pharmaceuticals Ltd, said he was proud of this single brand of the company reaching such high sales, although it had not reached Tk 1,000 crore yet. Since the customer base is high, the sales growth now appears low compared to previous years but there is potential for further growth, he said. The second and third-highest selling medicine brands are also from the same gastrological generic. Sales of Maxpro and Pantonix have reached Tk 486 crore and Tk 376 crore respectively. In the pharmaceuticals market, the market share of gastrologic products is the highest and Sergel has earned the highest market share over the years for its acceptance among doctors and patients, said Halimuzzaman. Among the 10 top-selling drug brands, five are gastrological medicines. Sergel holds a 2.67 percent market share, with sales worth Tk 918 crore in the nine-month period. Maxpro holds a 1.41 percent market share and the market share of Pantonix is 1.10 percent, the data showed. Apart from Sergel, some other brands have become popular over the years, said Halimuzzaman. The fourth-highest selling drug in the nine months period was Napa, with sales reaching Tk 338 crore. Sales of Cef-3, Monas, Exium, Seclo and Bizoran are also above Tk 200 crore. Almost all the drug companies have their own brands of these drugs, which bear the same molecular formula, but some gained popularity on gaining people's confidence. And this confidence passes from person to person, he said. There are 31 generic drugs that sell for over Tk 100 crore. The data showed that sales of 79 generic medicine were above Tk 50 crore. The data indicates that although the sales of individual brands of products of some companies may not be high, but the brand value of the companies themselves ensures high sales of all their medicines. Jubayer Alam, company secretary of Renata PLC, said most people over 18 years of age take gastrological medicine as there is no discipline when it comes to food intake and habits. Due to this, many people suffer from ailments affecting the digestive system, he said. Demand is growing for rosuvastatin drugs, which lowers cholesterol, as many people are dying of heart attacks, he added. Even in developed countries, demand for such medicine is growing, so it also may see a good growth in the country, he added. "We are really happy that we can serve a huge number of patients to overcome ulcer, gastroesophageal reflux disease and hyperacidity related problems with Maxpro," Alam said. "All Maxpro formulations are manufactured in USFDA, UKMHRA and Anvisa approved facilities so that patients get the best esomeprazole of the country," he added.
None